Search the MBS

Attendance by a medical practitioner (other than a specialist or consultant physician) for the assessment and management of a person with COVID-19 infection of recent onset and confirmed by either:

(a)     laboratory testing; or

(b)     a COVID-19 rapid antigen self-test which has been approved for supply in Australia by the Therapeutic Goods Administration, where:

 (i) the treating practitioner makes a record in the patient’s notes that the relevant state and territory reporting requirements have been           met, if applicable, and either:

a. confirms the patient has reported the positive test result to the relevant state or territory public health unit where reporting requirements are in place from time to time; or

b. assists the patient to report the positive result to the relevant state or territory public health unit where reporting requirements are in place from time to time.

Fee: $29.85 Benefit: 85% = $25.40

• Previous - Item 93705
• Next - Item 93716